Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

2009483 citationsJournal Article

Authors

Emad A. Rakha · Menoufia University

Somaia Elsheikh · Menoufia University

Mohammed A. Aleskandarany · Menoufia University

Hany O. Habashi · Nottingham University Hospitals NHS Trust

Andrew R. Green · Nottingham University Hospitals NHS Trust

Desmond G. Powe · Nottingham University Hospitals NHS Trust

Maysa E. El‐Sayed

Abstract

TN breast cancers encompass a remarkably heterogeneous group of tumors. Expression of basal markers identifies a biologically and clinically distinct subgroup of TN tumors, justifying the use of basal markers (in TN tumors) to define BLBC.

Topics & Keywords

Breast Cancer Treatment Studies HER2/EGFR in Cancer Research Cancer-related Molecular Pathways

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Cancer Research

Volume 15, Issue 7, pp. 2302-2310

DOI: 10.1158/1078-0432.ccr-08-2132

Field-Weighted Citation Impact: 18.84